About the Authors
- Ai Kawana-Tachikawa
-
Affiliations Irsicaixa AIDS Research Institute – HIVACAT, Autonomous University of Barcelona, Badalona, Spain, Division of Infectious Diseases, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
- Josep M. Llibre
-
Affiliation Lluita contra la SIDA Foundation, HIV Unit, University Hospital Germans Trias i Pujol, Badalona, UAB, Badalona, Spain
- Isabel Bravo
-
Affiliation Lluita contra la SIDA Foundation, HIV Unit, University Hospital Germans Trias i Pujol, Badalona, UAB, Badalona, Spain
- Roser Escrig
-
Affiliation Lluita contra la SIDA Foundation, HIV Unit, University Hospital Germans Trias i Pujol, Badalona, UAB, Badalona, Spain
- Beatriz Mothe
-
Affiliations Irsicaixa AIDS Research Institute – HIVACAT, Autonomous University of Barcelona, Badalona, Spain, Lluita contra la SIDA Foundation, HIV Unit, University Hospital Germans Trias i Pujol, Badalona, UAB, Badalona, Spain, University of Vic, Vic, Spain
- Jordi Puig
-
Affiliation Lluita contra la SIDA Foundation, HIV Unit, University Hospital Germans Trias i Pujol, Badalona, UAB, Badalona, Spain
- Maria C. Puertas
-
Affiliation Irsicaixa AIDS Research Institute – HIVACAT, Autonomous University of Barcelona, Badalona, Spain
- Javier Martinez-Picado
-
Affiliations Irsicaixa AIDS Research Institute – HIVACAT, Autonomous University of Barcelona, Badalona, Spain, University of Vic, Vic, Spain, Institució Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain
- Julia Blanco
-
Affiliations Irsicaixa AIDS Research Institute – HIVACAT, Autonomous University of Barcelona, Badalona, Spain, University of Vic, Vic, Spain
- Christian Manzardo
-
Affiliation Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain
- Jose M. Miro
-
Affiliation Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain
- Aikichi Iwamoto
-
Affiliation Division of Infectious Diseases, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
- Anton L. Pozniak
-
Affiliation HIV/GUM Department, Chelsea and Westminster Hospital, London, United Kingdom
- Jose M. Gatell
-
Affiliation Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain
- Bonaventura Clotet
-
Affiliations Irsicaixa AIDS Research Institute – HIVACAT, Autonomous University of Barcelona, Badalona, Spain, Lluita contra la SIDA Foundation, HIV Unit, University Hospital Germans Trias i Pujol, Badalona, UAB, Badalona, Spain, University of Vic, Vic, Spain
- Christian Brander
-
* E-mail: cbrander@irsicaixa.es
Affiliations Irsicaixa AIDS Research Institute – HIVACAT, Autonomous University of Barcelona, Badalona, Spain, University of Vic, Vic, Spain, Institució Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain
- the MARAVIBOOST investigators
-
¶Membership of the MARAVIBOOST investigators is provided in the Acknowledgments.
Competing Interests
This work was partly funded by Pfizer Inc and ViiV Healthcare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CB BM JB JMP AI ALP JML BC. Performed the experiments: AKT. Analyzed the data: IB RE MCP. Contributed reagents/materials/analysis tools: JML IB RE BM JP CM JMM JMG. Wrote the paper: AKT CB. Designed and executed the main Maraviboost clinical trial: MARAVIBOOST investigators.